Enhancement of Hematopoietic Stem Cell Repopulating Capacity and Self-Renewal in the Absence of the Transcription Factor C/EBPα-Reference-Cited by-同舟云学术

Enhancement of Hematopoietic Stem Cell Repopulating Capacity and Self-Renewal in the Absence of the Transcription Factor C/EBPα

Published:2004-12 Issue:6 Volume:21 Page:853-863
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Zhang Pu,Iwasaki-Arai Junko,Iwasaki Hiromi,Fenyus Maris L.,Dayaram Tajhal,Owens Bronwyn M.,Shigematsu Hirokazu,Levantini Elena,Huettner Claudia S.,Lekstrom-Himes Julie A.,Akashi Koichi,Tenen Daniel G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference42 articles.

1. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages;Akashi;Nature,2000

2. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML;Barjesteh van Waalwijk van Doorn-Khosrovani;Hematol. J,2003

3. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor;Dahl;Nat. Immunol,2003

4. C/ebpβ;Duprez;EMBO J,2003

5. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias;Gombart;Blood,2002

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CEBPA to restore cellular identity and tissue homeostasis in pulmonary fibrosis;JCI Insight;2024-07-16

2. CCAAT/enhancer‐binding protein α‐dependent regulation of granule formation in mast cells by intestinal bacteria;European Journal of Immunology;2024-07-09

3. Ribosome rescue factor PELOTA modulates translation start site choice for C/EBPα protein isoforms;Life Science Alliance;2024-05-21

4. CEBPA restricts alveolar type 2 cell plasticity during development and injury-repair;Nature Communications;2024-05-16

5. Transcription factor regulation of ribosomal RNA in hematopoiesis;Current Opinion in Hematology;2024-04-03